ParaZero Pokes Ahead on New Order
ParaZero Technologies Ltd. (NASDAQ: PRZO), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense Counter UAS systems, today announced that it has received a new order for dozens of units of its innovative SafeAir™ M4 system. The Tel Aviv-based company says the order was placed by a prominent European drone distributor that serves a wide range of commercial, public safety, and enterprise drone operators across the region.The SafeAir™ M4, ParaZero’s next-generation autonomous parachute recovery system, is designed for seamless integration with DJI’s Matrice 4 series. It features a newly developed deployment mechanism with real-time telemetry and is designed and expected to comply with the highest European regulatory standards to enable safe flight in urban areas throughout the EU.This newly secured order reflects a growing independent demand for ParaZero’s certified drone safety technologies across high-regulation markets in Europe.“This new order is yet another testament to the increasing recognition of the SafeAir M4 in drone safety systems,” said Boaz Shetzer, CEO of ParaZero. “We’re proud to see our solutions adopted by top-tier distributors and deployed in demanding commercial environments across Europe.”PRZO shares gained 8.7 cents, or 9.5%, to $1.00.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


